11008
G. A. N. Felton, N. L. Bauld / Tetrahedron 60 (2004) 10999–11010
76.3% (of required charge) had passed through the cell.
PTLC purification of the 87 mg of recovered crude yielded
cis-2d (34 mg, 33%), trans-2d (7 mg, 7%), and 3d (16 mg,
16%), for a total yield of 57 mg of pericyclic products
(56%). A further 6 mg (6%) of a product was isolated and
identified as 6d.
Electrolysis of 104 mg (0.0117 M) of 1e, with Et4NBF4
electrolyte and 25 mg of acetic acid, giving a 1.6:1 excess of
acetic acid. Initially at K2.5 V for 15.0 C and then at
K3.0 V for 32.0 C. PTLC purification of the crude yielded
trans-2e (6.0 mg, 6%), 5e (2.8 mg, 3%), 6e (14.1 mg, 14%),
and 7e (39.2 mg, 35%).
Electrolysis of 100 mg (0.0103 M) of 1d with Et4NBF4
electrolyte, at K3.2 V for 3.0 C (first 0.75 C at K2.5 V,
then 0.75 C at K3.0 V). This corresponds to 13.7% of
required charge. PTLC purification of the 150 mg of crude
yielded 3 mg (3%) of trans-2d, 17 mg (17%) of 5d, and
35 mg (35%) of an unidentified polymer.
Electrolysis of 98 mg (0.0110 M) of 1e with Bu4NBF4
electrolyte, at K1.5 V. The reaction was stopped after
3.4 C, or 14.5% (of required charge, corrected to 18.4%) had
passed through the cell. PTLC purification of the 122 mg of
recovered crude yielded cis-2e (16.6 mg, 21%), trans-2e
(13 mg, 17%), and 3e (8 mg, 10%), for a total yield of
37.6 mg of pericyclic products (48%). 20.4 mg (21%) of
starting material was recovered, along with 5 mg (6%) of 5e.
Reaction is 79% complete based upon recovered 1e.
4.7.1. Compound cis-2d.6 1H NMR (300 MHz, CDCl3):
1.74 (2H, m), 1.85 (2H, dd, JZ11.7, 3.3 Hz), 2.05 (2H, m),
3.19 (2H, d, JZ2.4 Hz), 3.77 (2H, d, JZ3.6 Hz), 7.46 (2H,
d, JZ8.4 Hz), 7.57 (2H, dd, JZ8.7, 2.1 Hz), 7.81 (2H, d,
JZ2.1 Hz); HRMS (CIC): calcd; 440.998266. Found;
440.997859.
4.8.1. Compound cis-2e.6 1H NMR (300 MHz, CDCl3)
1.74 (2H, m), 1.93 (2H, dd, JZ14.1, 5.4 Hz), 2.15 (2H, m),
3.29 (2H, d, JZ2.4 Hz), 4.08 (2H, d, JZ4.2 Hz), 7.45 (4H,
m), 7.74 (4H, m); 7.81 (4H, m), 8.22 (2H, s); HRMS (CIC):
calcd; 405.185455. Found 405.185760.
1
4.7.2. Compound trans-2d. H NMR (300 MHz, CDCl3):
1.38 (2H, m), 1.55 (1H, m), 1.83 (3H, m), 3.04 (1H, m), 3.24
(1H, m), 4.15 (1H, m), 4.47 (1H, dd, JZ2.1, 10.2 Hz), 7.55
(1H, d, JZ3.3 Hz), 7.57 (1H, d, JZ3.0 Hz), 7.76 (1H, br.d),
7.81 (1H, br.d), 8.02 (1H, d, JZ2.1 Hz) 8.08 (1H, d, JZ
1.8 Hz); HRMS (CIC): calcd; 440.998266. Found;
440.997697.
4.8.2. Compound trans-2e.6 1H NMR (300 MHz, CDCl3):
1.45 (1H, m), 1.62 (1H, m), 1.85 (2H, m), 1.99 (2H, m), 3.16
(1H, m), 3.35 (1H, m), 4.50 (1H, m), 4.79 (1H, dd, JZ2.4,
10.2 Hz), 7.58 (4H, m), 7.89 (4H, m), 8.03 (4H, br.m), 8.48
(1H, br.s), 8.60 (1H, br.s); HRMS (CIC): calcd;
405.185455. Found; 405.186095.
1
4.7.3. Compound 3d. H NMR (300 MHz, CDCl3): 1.60
4.8.3. Compound 3e.6 1H NMR (300 MHz, CDCl3): 1.60
(2H, m), 1.85 (2H, m), 2.07 (2H, m), 2.83 (2H, m), 5.09 (1H,
d, JZ6.9 Hz), 5.73 (1H, d, J!3 Hz), 7.39 (2H, m), 7.62
(3H, m), 7.74 (3H, m), 7.95 (4H, m), 8.15 (1H, m), 8.74 (1H,
br.s); HRMS (CIC): calcd; 405.185455. Found;
405.186005.
(2H, m), 1.85 (2H, m), 2.07 (2H, m), 2.83 (2H, m), 5.09 (1H,
d, JZ6.9 Hz), 5.73 (1H, d, J!3 Hz), 7.39 (2H, m), 7.62
(3H, m), 7.74 (3H, m), 7.95 (4H, m), 8.15 (1H, m), 8.74 (1H,
br.s); HRMS (CIC): calcd; 440.998266. Found;
440.997720.
1
4.7.4. Compound 5d. H NMR (300 MHz, CDCl3): 1.73
4.8.4. Compound 5e.11 1H NMR (300 MHz, CDCl3): 1.71
(1H, m), 1.87 (3H, m), 2.35 (2H, br.m), 3.00 (1H, dd, JZ
11.4, 15.6 Hz), 3.66 (1H, dd, JZ3.6, 15.6 Hz), 3.77 (1H,
br.s), 6.75 (1H, br.t), 7.60 (4H, m), 7.92 (5H, m), 7.99 (1H,
m), 8.05 (1H, m), 8.14 (1H, m), 8.22 (1H, s), 8.71 (1H, s).
(4H, m), 2.31 (2H, br.m), 2.84 (1H, dd, JZ9.6, 15.0 Hz),
3.66 (1H, dd, JZ3.6, 15.0 Hz), 3.40 (1H, br.s), 6.66 (1H, t,
JZ3.3 Hz), 7.51 (2H, m), 7.56 (1H, d, JZ8.4 Hz), 7.74
(1H, d, JZ1.8 Hz), 7.90 (1H, dd, JZ2.1, 8.4 Hz), 8.12 (1H,
d, JZ2.1 Hz); HRMS (CIC): calcd; 440.998266. Found;
440.998110.
4.8.5. Compound 6e.6 1H NMR (300 MHz, CDCl3). Partial
only: 1.60 (m), 1.91 (m), 3.20 (2H, m), 5.74 (1H, d, JZ
1.8 Hz), 7.41 (2H, m), 7.59 (6H, br.m), 7.76 (2H, m), 7.87
(2H, m), 8.00 (2H, m).
1
4.7.5. Compound 6d. H NMR (300 MHz, CDCl3): 1.71
(3H, m), 1.98 (1H, m), 2.17 (1H, m), 2.34 (1H, m), 2.96 (3H,
m), 3.17 (1H, br.d, JZ17.4 Hz), 3.65 (1H, d, JZ9.0 Hz),
5.24 (1H, d, J!1.5 Hz), 7.31 (1H, m), 7.54 (2H, m), 7.76
(1H, br.d), 7.81 (1H, d, JZ2.1 Hz), 8.00 (1H, m); HRMS
(CIC): calcd; 443.013916. Found; 443.012405.
1
4.8.6. Compound trans-7e. H NMR (300 MHz, CDCl3):
1.35 (1H, m), 1.67 (2H, m), 1.88 (1H, m), 2.04 (2H, m), 2.31
(1H, m), 2.78 (1H, m), 2.95 (1H, dd, JZ8.1, 15.6 Hz), 3.10
(1H, dd, JZ8.1, 16.2 Hz), 3.27 (1H, dd, JZ5.7, 15.3 Hz),
3.38 (1H, dd, JZ4.8, 16.2 Hz), 7.56 (4H, m), 7.88 (4H, m),
7.95 (2H, br.d, JZ7.8 Hz), 8.02 (2H, m), 8.47 (2H, br.d, JZ
6.0 Hz); HRMS (CIC): calcd; 407.201105. Found;
407.202010.
4.8. Electrolysis of E,E-1,7-di-1-naphthoyl-1,6-
heptadiene (1e)
Electrolysis of 97 mg (0.0109 M) of 1e with Bu4NBF4
electrolyte, at K1.8 V (first 3.0 C at K1.5 V). The reaction
appeared complete after 4.5 C, or 19.4% (of required
charge) had passed through the cell. PTLC purification of
the 123 mg of recovered crude yielded cis-2e (14 mg, 14%),
trans-2e (28 mg, 29%), and 3e (8 mg, 8%), for a total yield
of 50 mg of pericyclic products (51%). No starting material
was recovered. A further 16 mg (17%) of 5e was recovered.
4.9. Electrolysis of E,E-1,7-bis(4-phenylbenzoyl)-1,6-
heptadiene (1f)
Electrolysis of 76 mg (0.0076 M) of 1f with Bu4NBF4
electrolyte (in a 1:1 THF/acetonitrile solution), at K3.5 V
(first 1.8 C at K2.5 V, then 1.1 C at K3.0 V). The reaction